Plexus (NASDAQ:PLXS) Stock Rating Lowered by Wall Street Zen

Plexus (NASDAQ:PLXSGet Free Report) was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research report issued on Sunday.

Several other brokerages have also recently issued reports on PLXS. Stifel Nicolaus set a $140.00 price target on Plexus in a research report on Thursday, July 24th. Benchmark boosted their price target on Plexus from $160.00 to $165.00 and gave the company a “buy” rating in a research report on Monday, September 22nd. Sidoti raised Plexus from a “neutral” rating to a “buy” rating and increased their target price for the stock from $135.00 to $150.00 in a research note on Friday, July 25th. Needham & Company LLC cut their target price on Plexus from $162.00 to $158.00 and set a “buy” rating for the company in a research note on Thursday, July 24th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Plexus in a research note on Wednesday, October 8th. Three investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $155.60.

View Our Latest Report on PLXS

Plexus Stock Up 1.8%

Plexus stock opened at $151.16 on Friday. The company has a market capitalization of $4.08 billion, a P/E ratio of 25.75 and a beta of 0.80. Plexus has a fifty-two week low of $103.43 and a fifty-two week high of $172.89. The stock has a 50-day simple moving average of $139.89 and a 200-day simple moving average of $133.15. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.58.

Plexus (NASDAQ:PLXSGet Free Report) last issued its quarterly earnings results on Wednesday, July 23rd. The technology company reported $1.90 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.19. The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. Plexus had a return on equity of 12.33% and a net margin of 4.04%.The firm’s revenue for the quarter was up 6.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.45 EPS. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. Equities research analysts expect that Plexus will post 5.9 earnings per share for the current year.

Insiders Place Their Bets

In related news, CAO Angelo Michael Ninivaggi, Jr. sold 1,576 shares of the company’s stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $137.78, for a total value of $217,141.28. Following the sale, the chief accounting officer owned 24,495 shares in the company, valued at $3,374,921.10. This represents a 6.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Victor (Pang Hau) Tan sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, August 28th. The stock was sold at an average price of $139.00, for a total value of $417,000.00. Following the completion of the sale, the insider owned 8,723 shares in the company, valued at approximately $1,212,497. This represents a 25.59% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 15,856 shares of company stock worth $2,142,440. 1.76% of the stock is owned by insiders.

Institutional Investors Weigh In On Plexus

A number of large investors have recently bought and sold shares of the stock. Congress Asset Management Co. grew its holdings in Plexus by 0.5% during the 3rd quarter. Congress Asset Management Co. now owns 16,245 shares of the technology company’s stock valued at $2,350,000 after buying an additional 88 shares during the last quarter. Huntington National Bank grew its holdings in Plexus by 41.5% during the 2nd quarter. Huntington National Bank now owns 324 shares of the technology company’s stock valued at $44,000 after buying an additional 95 shares during the last quarter. Xponance Inc. grew its holdings in Plexus by 4.8% during the 1st quarter. Xponance Inc. now owns 2,315 shares of the technology company’s stock valued at $297,000 after buying an additional 106 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its holdings in Plexus by 7.1% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,750 shares of the technology company’s stock valued at $237,000 after buying an additional 116 shares during the last quarter. Finally, Inspire Investing LLC lifted its stake in shares of Plexus by 4.8% during the 1st quarter. Inspire Investing LLC now owns 2,682 shares of the technology company’s stock worth $344,000 after purchasing an additional 123 shares during the period. Institutional investors and hedge funds own 94.45% of the company’s stock.

About Plexus

(Get Free Report)

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.

Read More

Analyst Recommendations for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.